Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
TLRY 
Tilray Inc (TLRY)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: TLRY (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -62.32% | Avg. Invested days 23 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 611.01M USD | Price to earnings Ratio - | 1Y Target Price 1.79 |
Price to earnings Ratio - | 1Y Target Price 1.79 | ||
Volume (30-day avg) 36307630 | Beta 2.04 | 52 Weeks Range 0.58 - 2.97 | Updated Date 04/1/2025 |
52 Weeks Range 0.58 - 2.97 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.3 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-04-07 | When Before Market | Estimate - | Actual - |
Profitability
Profit Margin -30.02% | Operating Margin (TTM) -15.3% |
Management Effectiveness
Return on Assets (TTM) -1.45% | Return on Equity (TTM) -7.02% |
Valuation
Trailing PE - | Forward PE 1000 | Enterprise Value 715636032 | Price to Sales(TTM) 0.75 |
Enterprise Value 715636032 | Price to Sales(TTM) 0.75 | ||
Enterprise Value to Revenue 0.89 | Enterprise Value to EBITDA -4.84 | Shares Outstanding 933972992 | Shares Floating 931579189 |
Shares Outstanding 933972992 | Shares Floating 931579189 | ||
Percent Insiders 0.65 | Percent Institutions 11.72 |
Analyst Ratings
Rating 3.54 | Target Price 2.13 | Buy 1 | Strong Buy 3 |
Buy 1 | Strong Buy 3 | ||
Hold 9 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Tilray Inc
Company Overview
History and Background
Tilray Inc. was founded in 2013 and initially focused on providing medical cannabis products. It was one of the first cannabis companies to be listed on a major U.S. stock exchange (NASDAQ). Tilray merged with Aphria in 2021, creating a larger global cannabis company.
Core Business Areas
- Cannabis: Production, distribution, and sale of cannabis products for medical and recreational use. Includes dried flower, oils, edibles, and vaporizers.
- Beverages: Production and distribution of alcoholic beverages, primarily through its SweetWater Brewing Company.
- Wellness: Sale of CBD products through various brands including Manitoba Harvest.
- International: Expanding the business into foreign countries where cannabis is legal.
Leadership and Structure
Irwin D. Simon serves as the Chairman and CEO. The company operates with a functional organizational structure, with distinct divisions for cannabis, beverage, and wellness, supported by central functions like finance, marketing, and operations.
Top Products and Market Share
Key Offerings
- Dried Flower: Various strains and formats of dried cannabis flower for recreational and medical use. Market share is fragmented; competing with many smaller producers and larger players like Curaleaf and Canopy Growth. Difficult to determine exact market share for Tilray in this segment.
- Cannabis Oils and Extracts: Cannabis-derived oils and extracts for vaping or consumption. Similar market landscape to flower, with high competition. Competitors: Canopy Growth, Aurora Cannabis.
- SweetWater Brewing Company Beverages: Craft beers produced by SweetWater Brewing Company, a Tilray brand. Revenue is growing but market share in the broader beverage market is still relatively small, competing with major brewers like AB InBev and Molson Coors.
- CBD Products: CBD products offered through the Manitoba Harvest brand. Competitors: Charlotte's Web, CV Sciences.
Market Dynamics
Industry Overview
The cannabis industry is growing, driven by legalization trends and increasing acceptance of cannabis use. The industry is fragmented with intense competition, evolving regulatory landscapes, and varying legal frameworks across different jurisdictions. Beverage companies are in a competitive alcoholic beverage space
Positioning
Tilray Inc aims to be a global leader in the cannabis and consumer packaged goods sectors. It leverages its brands, distribution network, and international presence to compete. Competitive advantages include its brand portfolio, scale after the Aphria merger, and international footprint. These advantages are tempered by current financial perfomance.
Total Addressable Market (TAM)
The global cannabis market TAM is projected to reach hundreds of billions of dollars in the next decade. The alcoholic beverage industry is also in the hundreds of billions. Tilray is positioned to capture a share of both through organic growth and potential acquisitions.
Upturn SWOT Analysis
Strengths
- Strong brand portfolio
- Large scale after Aphria merger
- International presence
- Diversified product offerings
Weaknesses
- Inconsistent profitability
- High operating expenses
- Significant debt load
- Reliance on regulatory changes
Opportunities
- Further legalization in new jurisdictions
- Expansion of product offerings
- Strategic acquisitions
- Growth in international markets
Threats
- Intense competition
- Evolving and uncertain regulatory environment
- Price compression in the cannabis market
- Fluctuations in consumer demand
Competitors and Market Share
Key Competitors
- CGC
- ACB
- CRON
Competitive Landscape
Tilray competes with other major cannabis companies on price, brand recognition, and distribution network. Advantages lie in its diversified product portfolio, international presence, and cost controls. Disadvantages include inconsistent profit and large debt.
Major Acquisitions
SweetWater Brewing Company
- Year: 2020
- Acquisition Price (USD millions): 300
- Strategic Rationale: Expanded Tilray's presence in the beverage sector, diversifying its revenue streams and leveraging SweetWater's distribution network.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been marked by periods of rapid expansion followed by consolidation. Driven by acquisitions and legalization trends, but profitability has lagged. Difficult to predict without better historical performance.
Future Projections: Analysts expect future growth to be driven by further legalization, expansion of product lines, and international expansion. The extent of this growth is subject to regulatory and market conditions.
Recent Initiatives: Recent initiatives include focusing on international expansion, launching new product lines, and cost-cutting measures to improve profitability. Efforts on acquisitions in the US once federal regulatory hurdles are cleared.
Summary
Tilray is a major player in the global cannabis market, but its financial performance has been inconsistent. The company has a diversified product portfolio and international presence that could drive future growth if regulatory hurdles are cleared. However, intense competition, high debt, and challenging regulatory environments are all factors that could negatively impact performance. Revenue diversification is key.
Similar Companies
ACB
Aurora Cannabis Inc
ACB
Aurora Cannabis Inc
CGC
Canopy Growth Corp
CGC
Canopy Growth Corp
CRON
Cronos Group Inc
CRON
Cronos Group Inc
MO
Altria Group
MO
Altria Group
SMG
Scotts Miracle-Gro Company
SMG
Scotts Miracle-Gro Company
Sources and Disclaimers
Data Sources:
- Company Filings
- Analyst Reports
- Industry News
Disclaimers:
The information provided is for informational purposes only and does not constitute financial advice. Investment decisions should be based on individual circumstances and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Tilray Inc
Exchange NASDAQ | Headquaters Leamington, ON, Canada | ||
IPO Launch date 2018-07-19 | President, CEO & Chairman Mr. Irwin David Simon | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 2650 | Website https://www.tilray.com |
Full time employees 2650 | Website https://www.tilray.com | ||
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Beverage Alcohol, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Charlotte's Web, Montauk Brewing, Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point Brewing, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Bake Sale, The Batch, HEXO, Alpine Beer Company, Green Flash, Hiball Energy, Redhook Brewery, Square Mile Cider, Widmer Brothers Brewing, Runner's High Brewing Company, Happy Flower, and Fresh Hemp Foods brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.